Charles River Laboratories International price to free cash flow CRL

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026: 44.5×
10-year median: 23.9×
Against its 10-year history: 98th; percentile: 0 is its lowest day, 100 its highest
10-year range: 10.2× to 47.7×
Peer median: 29.9×

Charles River Laboratories International's price to free cash flow is 44.5× as of Oct 23, 2026.

That is above its ten-year median of 23.9×, higher than on 98% of days in the last ten years.

Over that time it ranged from 10.2× in Apr 2025 to 47.7× in Sep 2021.

The median for 10 diagnostics and research stocks of a similar size is 29.9×.

Price to free cash flow over time

median 23.9×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	44.5×	14.6×	44.5×
2025	18.4×	10.2×	18.4×
2024	17.0×	16.9×	38.3×
2023	32.9×	23.9×	45.5×
2022	39.6×	22.9×	44.8×
2021	42.1×	28.9×	47.7×
2020	27.8×	15.2×	29.9×
2019	25.2×	16.2×	26.0×
2018	16.5×	16.3×	24.5×
2017	22.7×	16.2×	22.7×
2016	15.6×	14.0×	17.0×
2015	16.8×	14.8×	20.4×
2014	17.6×	15.0×	17.8×
2013	14.9×	11.6×	14.9×
2012	11.6×	8.4×	13.6×
2011	8.2×	7.9×	17.9×

Against its peers

Companies in Medical - Diagnostics & Research nearest Charles River Laboratories International's size, closest first, today.

Company	Price to free cash flow
CRLCharles River Laboratories International	44.5×
RVTYRevvity	31.7×
MEDPMedpace	26.4×
LHLabcorp	23.1×
DGXQuest Diagnostics	19.8×
BIOBio-Rad Laboratories	28.0×
CAICaris Life Sciences	73.0×
MTDMettler-Toledo International	38.7×
ILMNIllumina	43.7×
LNTHLantheus	16.8×
IDXXIDEXX Laboratories	35.2×
Peer median	29.9×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Charles River Laboratories International

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.